Redhill Biopharma (STU:2RH) Days Payable : 0.00 (As of Dec. 2024)

View and export this data going back to 2015. Start your Free Trial

What is Redhill Biopharma Days Payable?

Redhill Biopharma's average Accounts Payable for the three months ended in Dec. 2024 was €4.64 Mil. Redhill Biopharma's Cost of Goods Sold for the three months ended in Dec. 2024 was €0.00 Mil.

The historical rank and industry rank for Redhill Biopharma's Days Payable or its related term are showing as below:

During the past 13 years, Redhill Biopharma's highest Days Payable was 636.86. The lowest was 77.85. And the median was 406.88.

STU:2RH's Days Payable is not ranked ^*
in the Drug Manufacturers industry.
Industry Median: 87.07
* Ranked among companies with meaningful Days Payable only.

Redhill Biopharma's Days Payable declined from Mar. 2023 (244.68) to Dec. 2024 (0.00). It may suggest that Redhill Biopharma accelerated paying its suppliers.

Redhill Biopharma Days Payable Historical Data

The historical data trend for Redhill Biopharma's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Redhill Biopharma Days Payable Chart

Redhill Biopharma Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Days Payable

Get a 7-Day Free Trial

79.82

82.73

83.02

402.69

629.47

Redhill Biopharma Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Dec23	Jun24	Dec24
Days Payable	Get a 7-Day Free Trial															244.68	426.20	-	-	-

Competitive Comparison of Redhill Biopharma's Days Payable

For the Drug Manufacturers - Specialty & Generic subindustry, Redhill Biopharma's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Redhill Biopharma's Days Payable Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Redhill Biopharma's Days Payable distribution charts can be found below:

* The bar in red indicates where Redhill Biopharma's Days Payable falls into.

Save Embed

;

Save Embed

;

Redhill Biopharma Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Redhill Biopharma's Days Payable for the fiscal year that ended in Dec. 2024 is calculated as

	Days Payable (A: Dec. 2024 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Dec. 2023 )	+	Accounts Payable (A: Dec. 2024 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2024 )	*	Days in Period
=	( (3.006	+	7.507)	/	2 )	/	3.048	*	365
=	5.2565					/	3.048	*	365
=	629.47

Redhill Biopharma's Days Payable for the quarter that ended in Dec. 2024 is calculated as:

	Days Payable (Q: Dec. 2024 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Jun. 2024 )	+	Accounts Payable (Q: Dec. 2024 ))	/	count )	/	Cost of Goods Sold (Q: Dec. 2024 )	*	Days in Period
=	( (1.776	+	7.507)	/	2 )	/	0	*	365 / 4
=	4.6415					/	0	*	365 / 4
=	N/A

Redhill Biopharma Days Payable Related Terms

Thank you for viewing the detailed overview of Redhill Biopharma's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Redhill Biopharma Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Redhill Biopharma Ltd (STU:2RH) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

RDHL:USA

Address

21 Ha’arba’a Street, Tel Aviv, ISR, 6473921

Website

https://www.redhillbio.com

Redhill Biopharma Ltd is a specialty biopharmaceutical company focused on gastrointestinal diseases. The company is dedicated to advancing its development pipeline of clinical-stage therapeutic candidates. It also commercializes GI-related products in the U.S., including Talicia (omeprazole, amoxicillin, and rifabutin) and Aemcolo (rifamycin). Currently, the company's pipeline consists of five therapeutic candidates: Opaganib, RHB-107, RHB-102, RHB-204, and RHB-104, the majority of which are in clinical development.

Redhill Biopharma Headlines

No Headlines